Literature DB >> 24995108

Relationship of ghrelin, acid uric and proinflammatory adipocytokines in different degrees of obesity or diabetes.

María Pilar Cruz-Domínguez1, Daniel H Montes Cortés1, Arturo Zarate2, María de Los Ángeles Tapia-González3, Sandra Alvarez-Acosta1, Leticia Damasio2, Leticia Manuel-Apolinar2.   

Abstract

We compared and examined factors associated with ghrelin and uric acid in obese subjects (OB), obese plus type 2 diabetes mellitus (OBDM) and healthy controls (C). Methods. We analyzed blood count, renal function, liver enzymes, lipids, resistin, leptin, IL-6, uric acid and ghrelin in OB, OBDM and C. We included 76 subjects with different body mass index (BMI): 36 C (24 ± 3), 11 OB<40 (30-39.9), 20 OB>40 (40-60), and 9 OBDM (45.9 ± 9). Results. Metabolic profile was as follows: HOMA-IR 4.7 ± 3 and 5 ± 3 vs 2 ± 1 (p < 0.01), resistin 8.7 ± 2 and 9.4 ± 2 vs 5.4 ± 2 ng/mL (p < 0.001), leptin 6.2 ± 3.9 and 5.3 ± 2 vs 3.6 ± 1.8 ng/mL (p = 0.001) and IL-6 197.5 ± 78.9 and 223.6 ± 115 vs 7.4 ± 8.3 pg/mL (p = 0.001) in OB and OBDM vs C, respectively. Ghrelin was higher in OB<40 compared to C (1780 ± 197 vs 1465 ± 12 pg/mL, p < 0.05), and lower in OBDM (987.4 ± 114 pg/mL, p < 0.05). BMI showed a positive correlation with resistin (p < 0.001); leptin (p = 0.004), IL-6 (p = 0.001), uric acid (p = 0.0005) and negative with ghrelin (r = -0.431, p = 0.028). Resistin was directly correlated with leptin (p < 0.001) and inversely correlated with renal function (p = 0.03). Conclusion. Severe obesity and obesity-associated diabetes affected ghrelin and uric acid levels. This may well be associated with proinflammatory adipocytokines, insulin resistance, liver enzymes or renal function.

Entities:  

Keywords:  Obesity; adipocytokines; diabetes; ghrelin; uric acid

Year:  2014        PMID: 24995108      PMCID: PMC4073769     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population.

Authors:  Haruhiko Osawa; Yasuharu Tabara; Ryuichi Kawamoto; Jun Ohashi; Masaaki Ochi; Hiroshi Onuma; Wataru Nishida; Kazuya Yamada; Jun Nakura; Katsuhiko Kohara; Tetsuro Miki; Hideichi Makino
Journal:  Diabetes Care       Date:  2007-03-23       Impact factor: 19.112

2.  Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss.

Authors:  J P Bastard; C Jardel; E Bruckert; P Blondy; J Capeau; M Laville; H Vidal; B Hainque
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

3.  Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.

Authors:  Gloria Lena Vega; Carolyn E Barlow; Scott M Grundy; David Leonard; Laura F DeFina
Journal:  J Investig Med       Date:  2014-02       Impact factor: 2.895

Review 4.  Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans.

Authors:  I L Williams; S B Wheatcroft; A M Shah; M T Kearney
Journal:  Int J Obes Relat Metab Disord       Date:  2002-06

5.  Molecular mechanisms of ghrelin-mediated endothelial nitric oxide synthase activation.

Authors:  Xiangbin Xu; Bong Sook Jhun; Chang Hoon Ha; Zheng-Gen Jin
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

6.  Physiologic concentrations of exogenously infused ghrelin reduces insulin secretion without affecting insulin sensitivity in healthy humans.

Authors:  Jenny Tong; Ronald L Prigeon; Harold W Davis; Martin Bidlingmaier; Matthias H Tschöp; David D'Alessio
Journal:  J Clin Endocrinol Metab       Date:  2013-04-15       Impact factor: 5.958

7.  Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity.

Authors:  Bulent O Yildiz; Marc A Suchard; Ma-Li Wong; Samuel M McCann; Julio Licinio
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-01       Impact factor: 11.205

Review 8.  National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants.

Authors:  Goodarz Danaei; Mariel M Finucane; Yuan Lu; Gitanjali M Singh; Melanie J Cowan; Christopher J Paciorek; John K Lin; Farshad Farzadfar; Young-Ho Khang; Gretchen A Stevens; Mayuree Rao; Mohammed K Ali; Leanne M Riley; Carolyn A Robinson; Majid Ezzati
Journal:  Lancet       Date:  2011-06-24       Impact factor: 79.321

9.  Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study.

Authors:  Giliola Calori; Guido Lattuada; Lorenzo Piemonti; Maria Paola Garancini; Francesca Ragogna; Marco Villa; Salvatore Mannino; Paolo Crosignani; Emanuele Bosi; Livio Luzi; Giacomo Ruotolo; Gianluca Perseghin
Journal:  Diabetes Care       Date:  2010-10-11       Impact factor: 19.112

10.  Uric acid as a risk factor for cardiovascular disease and mortality in overweight/obese individuals.

Authors:  Helle Skak-Nielsen; Christian Torp-Pedersen; Nick Finer; Ian D Caterson; Luc Van Gaal; W Philip T James; Aldo Pietro Maggioni; Arya M Sharma; Walmir Coutinho; Charlotte Andersson
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

View more
  9 in total

1.  Lipocalin-2 plasmatic levels are reduced in patients with long-term type 2 diabetes mellitus.

Authors:  Elsa De la Chesnaye; Leticia Manuel-Apolinar; Arturo Zarate; Leticia Damasio; Nancy Espino; María Cristina Revilla-Monsalve; Sergio Islas-Andrade
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Effect of Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for Type 2 Diabetes Control in an Obese Rat Model.

Authors:  Kaijing Wang; Xiaogang Zhou; Giang Quach; Jiajun Lu; Wei Gao; Anan Xu; Jiangfan Zhu
Journal:  Obes Surg       Date:  2016-04       Impact factor: 4.129

3.  Comparative analysis of the gut microbiota in distinct statin response patients in East China.

Authors:  Baoqing Sun; Luming Li; Xinfu Zhou
Journal:  J Microbiol       Date:  2018-11-27       Impact factor: 3.422

4.  Curative effect of Tai Chi exercise in combination with auricular plaster therapy on improving obesity patient with secondary hyperlipidemia.

Authors:  Qinghua Song; Yandong Yuan; Chun Jiao; Ximei Zhu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

5.  Treatment of renal uric acid stone by extracorporeal shock wave lithotripsy combined with sodium bicarbonate: 2 case reports.

Authors:  Hao-Yong Li; Pei-Yu Lian; Zhi-Yan Zhou; Peng Song; Yi Yan; Ji-Hong Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 6.  Neurobiochemical and psychological factors influencing the eating behaviors and attitudes in anorexia nervosa.

Authors:  Teresa Grzelak; Agata Dutkiewicz; Elzbieta Paszynska; Monika Dmitrzak-Weglarz; Agnieszka Slopien; Marta Tyszkiewicz-Nwafor
Journal:  J Physiol Biochem       Date:  2016-12-06       Impact factor: 4.158

7.  Neuropeptide B and Vaspin as New Biomarkers in Anorexia Nervosa.

Authors:  Teresa Grzelak; Marta Tyszkiewicz-Nwafor; Agata Dutkiewicz; Aniceta Ada Mikulska; Monika Dmitrzak-Weglarz; Agnieszka Slopien; Krystyna Czyzewska; Elzbieta Paszynska
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

8.  Association between Sex Hormone and Blood Uric Acid in Male Patients with Type 2 Diabetes.

Authors:  Wen Cao; Ren-Dong Zheng; Shu-Hang Xu; Yao-Fu Fan; Hong-Ping Sun; Chao Liu
Journal:  Int J Endocrinol       Date:  2017-10-03       Impact factor: 3.257

9.  The Correlation Between Circulating Ghrelin and Insulin Resistance in Obesity: A Meta-Analysis.

Authors:  Cai-Shun Zhang; Liu-Xin Wang; Rui Wang; Yuan Liu; Li-Min Song; Jun-Hua Yuan; Bin Wang; Jing Dong
Journal:  Front Physiol       Date:  2018-09-21       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.